Company Spotlight

Aphena Pharma Solutions, Inc.

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile


Contract Service Directory


Legacy Pharmaceutical Packaging





Company Headquarters

13333 Lakefront Drive
Earth City, MO 63045
United States

Company Description

Legacy Pharmaceutical Packaging is a privately held contract packaging company located in St. Louis, Missouri. Operating out of a combined 300,000 sq ft cGMP compliant facilities, Legacy is a full-service pharma solution provider servicing the branded, generic, government, wholesale and major retail markets. Legacy is built for rapid response and specializes in high speed bottle filling, blistering, compliance and unit-of-use packaging and offers a wide range of secondary packaging and kitting solutions. Legacy is registered with the FDA, VAWD accredited and licensed by the DEA to handle Schedule II-V drug product. Legacy is equipped and ready to handle your inline or secondary serialization needs to help bring your product to market.

Contract Service Directory

    Related Content

    • Breaking News | Industry News | Logistics
      Legacy Pharmaceutical Packaging Adds Facility for 3PL Ops

      Legacy Pharmaceutical Packaging Adds Facility for 3PL Ops

      Total footprint now exceeds 500,000 sq.-ft.
      Contract Pharma Staff 11.06.20

    • Breaking News | CRO News | Promotions & Moves
      Parexel Adds Experts to Regulatory Consulting Group

      Parexel Adds Experts to Regulatory Consulting Group

      Four new hires from U.S. FDA and MHRA will serve as technical vice presidents
      12.10.19

    • Breaking News | Drug Development | Trials & Filings
      SK Bio Gains FDA Approval for XCOPRI

      SK Bio Gains FDA Approval for XCOPRI

      Marks the first time a Korean company has independently brought a compound from discovery to U.S. FDA approval
      11.25.19


    • Cold Chain Management | Logistics | Serialization | Supply Chain

      Review of FDA DSCSA Guidance Documents

      Brian Daleiden of TraceLink reviews the latest requirements from the FDA and DSCSA

    • Biologics, Proteins, Vaccines | Biosimilars
      Biopharma Over 20 Years

      Biopharma Over 20 Years

      A look at the key trends that have impacted the biopharma industry over the years.
      K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19

    • Solid Dosage/Semi-solids
      Pharma Packaging Solutions

      Pharma Packaging Solutions' Scott Garverick

      Pharma Packaging Solutions' vice president of business development discussed company capabilities at Contract Pharma 2019.
      Contract Pharma Staff




    • Regulatory Affairs
      Inactive Ingredients: Where Guidance Needs to Meet Data

      Inactive Ingredients: Where Guidance Needs to Meet Data

      Looking at FDA’s most recent draft guidance and the struggle with inactive ingredients.
      Sharif Ahmed, Lachman Consultants Services 10.15.19


    • Breaking News | Industry News
      VIDEO: Pharma Packaging Solutions

      VIDEO: Pharma Packaging Solutions' Scott Garverick

      Pharma Packaging Solutions' vice president of business development discussed company capabilities at Contract Pharma 2019.
      10.04.19

    • Regulatory Affairs
      Quality Metrics Feedback

      Quality Metrics Feedback

      A look at FDA’s Quality Metrics Initiative, a complicated issue for all of pharma stakeholders
      Gil Roth, President, Pharma & Biopharma Outsourcing Association 09.16.19

    • Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
      FDA Extends CRADA with CluePoints

      FDA Extends CRADA with CluePoints

      Aims to further explore a data-driven approach to quality oversight in clinical trials
      09.11.19


    • Trials & Filings
      FDA Approves New Treatment for Drug-Resistant TB

      FDA Approves New Treatment for Drug-Resistant TB

      Pretomanid is only the third new anti-TB drug approved by FDA in more than 40 years
      08.15.19

    • cGMP Manufacture | Collaborations & Alliances
      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      CRADA enables FDA and NIIMBL to support investments in regulatory science research, and training needed to foster advanced manufacturing innovations
      08.01.19


    • Trials & Filings
      FDA Accepts RedHill Biopharma’s NDA for Talicia

      FDA Accepts RedHill Biopharma’s NDA for Talicia

      Commercial launch of H. pylori treatment is planned shortly following potential FDA approval
      07.16.19

    • Extractables and Leachables | Laboratory Testing
      The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?

      The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?

      Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standards
      Kristin Brooks, Contract Pharma 07.11.19

    • Trials & Filings
      Sierra’s Momelotinib Granted FDA Fast Track Designation

      Sierra’s Momelotinib Granted FDA Fast Track Designation

      Underscores potential for momelotinib to address unmet needs of patients with Intermediate/High-Risk myelofibrosis who have previously received a JAK inhibitor
      06.19.19